News > Bharat Biotech gets nasal vaccine nod for use as mix-match booster

Bharat Biotech gets nasal vaccine nod for use as mix-match booster

Bharat Biotech’s intranasal Covid-19 vaccine iNCOVACC has received the Indian drug regulator’s nod to be used as a heterologous booster (a mix-and-match dose after the primary dose). This nasal vaccine becomes the second-approved Covid-19 vaccine in India, after Biological E’s Corbevax, which can be used as a mix-and-match booster shot. But the DCGI had approved iNCOVACC as a primary dose vaccine for Covid-19.